7th Lynch Syndrome Evening


For families who want to learn the latest on
Lynch Syndrome
formerly known as Hereditary Non-Polyposis Colorectal Cancer (HNPCC)

Date:             Wednesday, November 1, 2017

Place:            Mount Sinai Hospital, 600 University Avenue, Toronto

                        18th Floor Auditorium 

Time:             7:00 p.m. – 9:30 p.m.

Refreshments at 6:45pm




Welcome and Moderator:

Dr. Steve Gallinger

Director, Zane Cohen Centre for Digestive Diseases and Co-Director of the FGICR

The latest update in genetics (Slides)
Dr. Raymond Kim
Dr. Kim is the geneticist at the Zane Cohen Centre for Digestive Diseases and other hereditary cancer clinics in downtown Toronto. He will review the latest updates in the Federal law to prevent genetic discrimination, new testing families suspected of having Lynch syndrome, and the emerging genetic repair technology called CRISPR.

Immunotherapy - a new therapy to treat Lynch Syndrome cancers?  (Slides)
Dr. Uri Tabori
Dr. Tabori is an oncologist at the Hospital for Sick Children in Toronto and head of an international consortium for
children who inherit Lynch syndrome from both sides of the family. He runs a clinical trial for immunotherapy,
which is a new type of drug that may be an important therapy to treat Lynch syndrome cancers.

Stomach cancer and screening in Lynch Syndrome (Slides
Dr. Savtaj Brar
Dr. Brar is a surgical oncologist at Mount Sinai Hospital and heads up a high-risk screening program for families at
risk for developing stomach cancer. He will review stomach cancer and discuss whether screening is needed in
Lynch syndrome families.

Patient’s Perspective (Slides)
Teresa Tiano
Teresa will share her experiences with Lynch syndrome.

Question Period  
 A chance for you to ask questions of our expert panel  

For questions, please email: Melyssa.Aronson@sinaihealthsystem.ca or phone: 416-586-4800 ext. 2401 or 1-877-586-5112 ext. 0

This event is sponsored by Ann McLaughlin and Joe Aiello.